{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:22:42Z","timestamp":1778602962918,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,20]]},"DOI":"10.7759\/cureus.77708","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T14:57:26Z","timestamp":1737385046000},"source":"Crossref","is-referenced-by-count":1,"title":["Balancing the Treatment of Kaposi Sarcoma and Bullous Pemphigoid: A Therapeutic Challenge in a 63-Year-Old Male"],"prefix":"10.7759","author":[{"given":"Amritpal","family":"Kooner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle  R","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhruv","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Dutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conor","family":"Dolehide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2012-0101-RS","article-title":"Kaposi sarcoma","volume":"137","author":"Radu O","year":"2013","unstructured":"Radu O, Pantanowitz L. Kaposi sarcoma. Arch Pathol Lab Med. 2013, 137:289-94. 10.5858\/arpa.2012-0101-RS","journal-title":"Arch Pathol Lab Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20199007","article-title":"Bullous pemphigoid","volume":"94","author":"Miyamoto D","year":"2019","unstructured":"Miyamoto D, Santi CG, Aoki V, Maruta CW. Bullous pemphigoid. An Bras Dermatol. 2019, 94:133-46. 10.1590\/abd1806-4841.20199007","journal-title":"An Bras Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16318","article-title":"Treatments for AIDS\/HIV-related Kaposi sarcoma: a systematic review of the literature","volume":"61","author":"Liew YC","year":"2022","unstructured":"Liew YC, Tam YC, Oh CC. Treatments for AIDS\/HIV-related Kaposi sarcoma: a systematic review of the literature. Int J Dermatol. 2022, 61:1311-24. 10.1111\/ijd.16318","journal-title":"Int J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036068","article-title":"The epidemiology of classic, African, and immunosuppressed Kaposi's sarcoma","volume":"13","author":"Wahman A","year":"1991","unstructured":"Wahman A, Melnick SL, Rhame FS, Potter JD. The epidemiology of classic, African, and immunosuppressed Kaposi's sarcoma. Epidemiol Rev. 1991, 13:178-99. 10.1093\/oxfordjournals.epirev.a036068","journal-title":"Epidemiol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2478\/rjim-2020-0017","article-title":"Update on Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) - review","volume":"58","author":"Iftode N","year":"2020","unstructured":"Iftode N, R\u0103dulescu MA, Aram\u0103 \u0218S, Aram\u0103 V. Update on Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) - review. Rom J Intern Med. 2020, 58:199-208. 10.2478\/rjim-2020-0017","journal-title":"Rom J Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdmv.2023.10.007","article-title":"Lymphedema and Kaposi sarcoma: a narrative review","volume":"48","author":"Dauguet M","year":"2023","unstructured":"Dauguet M, Lebb\u00e9 C, Vignes S. Lymphedema and Kaposi sarcoma: a narrative review. J Med Vasc. 2023, 48:181-7. 10.1016\/j.jdmv.2023.10.007","journal-title":"J Med Vasc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-03502-0_3","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus (KSHV)-associated disease in the AIDS patient: an update","volume":"177","author":"Dittmer DP","year":"2019","unstructured":"Dittmer DP, Damania B. Kaposi\u2019s sarcoma-associated herpesvirus (KSHV)-associated disease in the AIDS patient: an update. Cancer Treat Res. 2019, 177:63-80. 10.1007\/978-3-030-03502-0_3","journal-title":"Cancer Treat Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01506","article-title":"New insights into the pathogenesis of bullous pemphigoid: 2019 update","volume":"10","author":"Genovese G","year":"2019","unstructured":"Genovese G, Di Zenzo G, Cozzani E, Berti E, Cugno M, Marzano AV. New insights into the pathogenesis of bullous pemphigoid: 2019 update. Front Immunol. 2019, 10:1506. 10.3389\/fimmu.2019.01506","journal-title":"Front Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2002.01151.x","article-title":"Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential","volume":"27","author":"Stanley MA","year":"2002","unstructured":"Stanley MA. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol. 2002, 27:571-7. 10.1046\/j.1365-2230.2002.01151.x","journal-title":"Clin Exp Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2174\/138955706776876131","article-title":"Topical imiquimod: mechanism of action and clinical applications","volume":"6","author":"Vidal D","year":"2006","unstructured":"Vidal D. Topical imiquimod: mechanism of action and clinical applications. Mini Rev Med Chem. 2006, 6:499-503. 10.2174\/138955706776876131","journal-title":"Mini Rev Med Chem"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1445947","article-title":"Genital warts treatment: beyond imiquimod","volume":"14","author":"Yuan J","year":"2018","unstructured":"Yuan J, Ni G, Wang T, Mounsey K, Cavezza S, Pan X, Liu X. Genital warts treatment: beyond imiquimod. Hum Vaccin Immunother. 2018, 14:1815-9. 10.1080\/21645515.2018.1445947","journal-title":"Hum Vaccin Immunother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-022-02490-5","article-title":"Treatment of actinic keratosis: a systematic review","volume":"315","author":"Worley B","year":"2023","unstructured":"Worley B, Harikumar V, Reynolds K, et al.. Treatment of actinic keratosis: a systematic review. Arch Dermatol Res. 2023, 315:1099-108. 10.1007\/s00403-022-02490-5","journal-title":"Arch Dermatol Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200405060-00010","article-title":"Role of imiquimod in skin cancer treatment","volume":"5","author":"Urosevic M","year":"2004","unstructured":"Urosevic M, Dummer R. Role of imiquimod in skin cancer treatment. Am J Clin Dermatol. 2004, 5:453-8. 10.2165\/00128071-200405060-00010","journal-title":"Am J Clin Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.11.005","article-title":"Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: a phase I to II, open-label trial in 17 patients","volume":"58","author":"C\u00e9lestin Schartz NE","year":"2008","unstructured":"C\u00e9lestin Schartz NE, Chevret S, Paz C, Kerob D, Verola O, Morel P, Lebb\u00e9 C. Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: a phase I to II, open-label trial in 17 patients. J Am Acad Dermatol. 2008, 58:585-91. 10.1016\/j.jaad.2007.11.005","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2006.02829.x","article-title":"Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream","volume":"45","author":"Rosen T","year":"2006","unstructured":"Rosen T. Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream. Int J Dermatol. 2006, 45:854-6. 10.1111\/j.1365-4632.2006.02829.x","journal-title":"Int J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2008.34397.x","article-title":"Treatment of classic Kaposi's sarcoma with topical imiquimod","volume":"35","author":"Goiriz R","year":"2009","unstructured":"Goiriz R, R\u00edos-Buceta L, De Arriba AG, Arag\u00fc\u00e9s M, Garc\u00eda-Diez A. Treatment of classic Kaposi's sarcoma with topical imiquimod. Dermatol Surg. 2009, 35:147-9. 10.1111\/j.1524-4725.2008.34397.x","journal-title":"Dermatol Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0850","article-title":"Imiquimod for the treatment of classical Kaposi's sarcoma","volume":"90","author":"Bernardini B","year":"2010","unstructured":"Bernardini B, Faggion D, Calabr\u00f3 L, Oro E, Alaibac M. Imiquimod for the treatment of classical Kaposi's sarcoma. Acta Derm Venereol. 2010, 90:417-8. 10.2340\/00015555-0850","journal-title":"Acta Derm Venereol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X231164222","article-title":"Imiquimod-induced bullous pemphigoid: a case report","volume":"11","author":"Li HO","year":"2023","unstructured":"Li HO, Aw M, Glassman SJ. Imiquimod-induced bullous pemphigoid: a case report. SAGE Open Med Case Rep. 2023, 11:2050313X231164222. 10.1177\/2050313X231164222","journal-title":"SAGE Open Med Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/313222-balancing-the-treatment-of-kaposi-sarcoma-and-bullous-pemphigoid-a-therapeutic-challenge-in-a-63-year-old-male","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T14:57:28Z","timestamp":1737385048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/313222-balancing-the-treatment-of-kaposi-sarcoma-and-bullous-pemphigoid-a-therapeutic-challenge-in-a-63-year-old-male"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.77708","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,20]]}}}